Adlai Nortye Ltd American Depositary Shares (ANL) has had the highest return since January 1, 2026 by a US stock in the Biotechnology Industry, returning 851.4%.
| ASSET | % RETURN |
|---|---|
Adlai Nortye Ltd American Depositary Shares (ANL) | 851.41% |
Edesa Biotech (EDSA) | 800% |
AN2 Therapeutics (ANTX) | 324.11% |
Immunitybio (IBRX) | 294.55% |
Sutro Biopharma (STRO) | 238.87% |
XWELL (XWEL) | 206.25% |
Zentalis Pharmaceuticals Llc (ZNTL) | 200% |
TuHURA Biosciences (HURA) | 200% |
Erasca (ERAS) | 175.74% |
MacroGenics (MGNX) | 163.98% |
Climb Bio (CLYM) | 163.41% |
Moolec Science SA Ordinary Shares (MLEC) | 159.97% |
Rallybio (RLYB) | 159.06% |
Cyclerion Therapeutics (CYCN) | 149.6% |
Cue Biopharma (CUE) | 148.06% |
Eledon Pharmaceuticals (ELDN) | 143.59% |
Century Therapeutics (IPSC) | 141.24% |
InflaRx (IFRX) | 139.81% |
Alumis (ALMS) | 134.08% |
Tango Therapeutics (TNGX) | 132.32% |
Day One Biopharmaceuticals (DAWN) | 131.75% |
Spyre Therapeutics (SYRE) | 128.69% |
Nanobiotix (NBTX) | 126.77% |
Artiva Biotherapeutics, Inc Common Stock (ARTV) | 125.87% |
Immunic (IMUX) | 117.27% |